dynaCERT Announces Shares for Debt Settlement
22 sept. 2017 16h20 HE
|
dynaCERT Inc.
TORONTO, Sept. 22, 2017 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE:DYA) (OTCQB:DYFSF) ("dynaCERT" or the "Company") announces that in accordance with the agreement previously disclosed in the...
Agile Therapeutics Announces Positive Top-line Phase 3 Results
03 janv. 2017 16h11 HE
|
Agile Therapeutics, Inc.
Resubmission of Twirla® New Drug Application Expected to Address FDA’s Complete Response LetterCompany Plans to Resubmit NDA in First Half of...
GlobalWafers and SunEdison Semiconductor Announce Receipt of Approval from SunEdison Semiconductor’s Shareholders for Proposed Acquisition
07 nov. 2016 09h20 HE
|
SunEdison Semiconductor Ltd
HSINCHU, Taiwan and ST. PETERS, Mo., Nov. 07, 2016 (GLOBE NEWSWIRE) -- GlobalWafers Co., Ltd. (“GlobalWafers”) and SunEdison Semiconductor Limited (NASDAQ:SEMI) (“SunEdison Semiconductor”) announced...
SunEdison Semiconductor Announces Regulatory Approvals from Taiwan and Austria for Proposed Acquisition
04 nov. 2016 07h15 HE
|
SunEdison Semiconductor Ltd
ST. PETERS, Mo., Nov. 04, 2016 (GLOBE NEWSWIRE) -- SunEdison Semiconductor Limited (NASDAQ:SEMI) (“SunEdison Semiconductor”) announced today that it has received notice that the Investment Committee...
Biotricity Files for FDA 510(k)
20 juin 2016 08h30 HE
|
Biotricity
REDWOOD CITY, Calif., June 20, 2016 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative,...
Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference
30 mars 2016 16h10 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 30, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation by the European Medicines Agency for Ampligen to Treat Patients With Ebola Virus Disease (EVD)
11 mai 2015 08h30 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 11, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that its European subsidiary, Hemispherx Biopharma Europe N.V./S.A.,...
Beamz Interactive, Inc.'s Product Earns Seal of Approval by The National Parenting Center
02 mai 2014 08h01 HE
|
Beamz Interactive, Inc.
SCOTTSDALE, AZ--(Marketwired - May 2, 2014) - Beamz Interactive, Inc. (OTCQB: BZIC), a leading developer of state-of-the-art interactive music products, today announced that the company's Beamz by...
Hemispherx Biopharma Announces Plans to File for Regulatory Approval of Ampligen(R) to Treat Chronic Fatigue Syndrome (CFS) in Three Additional Latin America Countries
10 mars 2014 11h00 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, March 10, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that it and its partner in Latin America, GP Pharm, are planning...
Toltec Financial Adopts Credit Track Loan Origination Platform From Global Wave Group
22 avr. 2008 12h29 HE
|
Global Wave Group; Toltec Financial, Inc.
LOS ANGELES, CA--(Marketwire - April 22, 2008) - Toltec Financial, Inc. has
engaged Global Wave Group to
automate their loan process. Toltec was in the market for a flexible and
scalable solution to...